These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Developing academic work and evidence to guide the practice of inpatient dermatology. Micheletti RG Semin Cutan Med Surg; 2017 Mar; 36(1):35-37. PubMed ID: 28247874 [TBL] [Abstract][Full Text] [Related]
43. [AIDS prevention in Germany]. Pott E Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Apr; 50(4):422-31. PubMed ID: 17387442 [TBL] [Abstract][Full Text] [Related]
44. [Rare diseases in professional health care]. Lelgemann M; Francke R Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 May; 51(5):509-18. PubMed ID: 18696142 [TBL] [Abstract][Full Text] [Related]
45. [The German network for systemic sclerosis (DNSS): current data on diagnostics and therapy]. Hunzelmann N; Krieg T; Hautarzt; 2012 Apr; 63 Suppl 1():71-5. PubMed ID: 22543950 [TBL] [Abstract][Full Text] [Related]
47. Polish activity within Orphanet Europe--state of art of database and services. Jezela-Stanek A; Karczmarewicz D; Chrzanowska KH; Krajewska-Walasek M Dev Period Med; 2015; 19(4):536-41. PubMed ID: 26982769 [TBL] [Abstract][Full Text] [Related]
48. [Speak up for people with rare diseases: ACHSE : ACHSE, Rare Diseases Germany, and its network]. Mundlos C Internist (Berl); 2018 Dec; 59(12):1327-1334. PubMed ID: 30377713 [TBL] [Abstract][Full Text] [Related]
49. [Rare diseases, a public health issue]. Donnart A; Viollet V; Roinet-Tournay M Soins Pediatr Pueric; 2013; (274):17-9. PubMed ID: 24228329 [TBL] [Abstract][Full Text] [Related]
51. The Past and Future of Rare Skin Disease Research and Therapy. Onoufriadis A; McGrath JA J Invest Dermatol; 2022 Apr; 142(4):1010-1014. PubMed ID: 35131257 [TBL] [Abstract][Full Text] [Related]
52. [Healthcare services for people in Lower Saxony (Germany) suffering from a rare disease: Findings from a survey among medical professionals]. Pauer F; Pflaum U; Lührs V; Frank M; Graf von der Schulenburg JM Z Evid Fortbild Qual Gesundhwes; 2016; 113():36-44. PubMed ID: 27480187 [TBL] [Abstract][Full Text] [Related]
55. [Rare diseases in pulmonary medicine and its challenges]. Wencker M; Teschler H; Vogelmeier C; Koczulla R Pneumologie; 2012 Jul; 66(7):437-41. PubMed ID: 22692970 [TBL] [Abstract][Full Text] [Related]
56. The value of research collaborations and consortia in rare cancers. Blay JY; Coindre JM; Ducimetière F; Ray-Coquard I Lancet Oncol; 2016 Feb; 17(2):e62-e69. PubMed ID: 26868355 [TBL] [Abstract][Full Text] [Related]
57. Focus on designing health care structures and services for rare diseases. Schultz C; Schreyögg J; Stargardt T; Busse R Health Policy; 2012 May; 105(2-3):107-9. PubMed ID: 22469233 [No Abstract] [Full Text] [Related]
58. Need to improve clinical trials in rare neurodegenerative disorders. Puopolo M; Pocchiari M Ann Ist Super Sanita; 2011; 47(1):55-9. PubMed ID: 21430340 [TBL] [Abstract][Full Text] [Related]
59. Towards government-funded special biomedical research programs to combat rare diseases in China. Chen K; Yao L; Liu Z Biosci Trends; 2015 Apr; 9(2):88-90. PubMed ID: 25902953 [TBL] [Abstract][Full Text] [Related]